Health

Novo Nordisk's Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US

Novo Nordisk announced that starting Monday, May 4, Ozempic® (semaglutide) tablets 1.5 mg, 4 mg, and 9 mg will be available for adults with type 2 diabetes in the US. Ozempic® is the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes indicated not only to improve blood sugar, along with diet and exercise, but also to reduce the risk of major cardiovascular events (MACE) such as heart attack, stroke, or death in those who are also at high risk for these events.1 Oral

articleNovo Nordisk A/s Class BMay 1, 202612/company/novo-nordisk-as-class-b/news/novo-nordisks-ozempicr-pill-the-only-fda-approved-oral-peptide-glp-1-medication-for-adults-with-type-2-diabetes-soon-to-be-available-in-the-us
Novo Nordisk's Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US

About this update from Novo Nordisk A/s Class B

[{"type":"list","items":[{"val":[{"type":"text","content":"With an updated formulation of semaglutide tablets and new branding, Ozempic® will be available in a pill","length":105,"tagName":"p"}]},{"val":[{"type":"text","content":"Ozempic® (semaglutide) pill is the only oral GLP-1 medicine approved for both primary and secondary cardiovascular risk reduction of heart attack, stroke, and death in adults with type 2 diabetes at high risk for these events, including those with known heart disease1","length":268,"tagName":"p"}]},{"val":[{"type":"text","content":"Ozempic® pill will be covered by insurance for most patients with type 2 diabetes for as little as $25 and available via self-pay through NovoCare® Pharmacy and major telehealth providers","length":187,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":560,"olType":false},{"type":"text","content":"PLAINSBORO, N.J., May 1, 2026 /PRNewswire/ -- Novo Nordisk announced that starting Monday, May 4, Ozempic® (semaglutide) tablets 1.5 mg, 4 mg, and 9 mg will be available for adults with type 2 diabetes in the US. Ozempic® is the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes indicated not only to improve blood sugar, along with diet and exercise, but also to reduce the risk of major cardiovascular events (MACE) such as heart attack, stroke, or death in those who are also at high risk for these events.1 Oral semaglutide for type 2 diabetes has been available as Rybelsus® in a different formulation and set of doses.","length":654,"tagName":"p"},{"type":"image","alt":"Bottles and pills shown are for the 4 mg and the 9 mg doses. Pill and bottle are not to scale.","displaySize":"","headline":null,"caption":"Bottles and pills shown are for the 4 mg and the 9 mg doses. Pill and bottle are not to scale.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":161,"url":"https://media.zenfs.com/en/prnewswire.com/79703389982b278aa19181fdc125a5cb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yZvGgO7C39xnvan5QuWWRQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI4NA--/https://media.zenfs.com/en/prnewswire.com/79703389982b278aa19181fdc125a5cb","width":400,"height":161}},"href":"https://mma.prnewswire.com/media/2970701/Novo_Nordisk_Ozempic_pills.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""Ozempic® has become a leading, trus...

More updates from Novo Nordisk A/s Class B

Novo Nordisktype 2 diabetescardiovascular riskhealth care providerheart attackdiabetessemaglutideblood sugarcardiovascular risk reductionkidney disease